Inhibition of carnitine biosynthesis by valproic acid in rats - The biochemical mechanism of inhibition

Biochemical Pharmacology

Volumn 52, Issue 9, 1996, Pages 1429-1433

  Farkas, Viktoria ^a   Bock, Ildiko ^a   Cseko, Joseph ^a   Sandor, Attila ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b NONE

Author keywords

ketoglutarate; butyrobetaine; carnitine biosynthesis; carnitine deficiency; epilepsy; L glutamate; valproic acid

Indexed keywords

2 OXOGLUTARIC ACID; ANTICONVULSIVE AGENT; BENZOIC ACID; CARNITINE; COENZYME A; GAMMA BUTYROBETAINE; GAMMA BUTYROBETAINE DIOXYGENASE; GLUTAMIC ACID; PIVALIC ACID; RADIOISOTOPE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CARNITINE DEFICIENCY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT;

ACETYL COENZYME A; ANIMALS; ANTICONVULSANTS; BETAINE; CARNITINE; COENZYME A; GLUTAMIC ACID; HUMANS; KETOGLUTARIC ACIDS; LIVER; MALE; RATS; RATS, WISTAR; VALPROIC ACID;

EID: 0030575912     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00507-2     Document Type: Article

References (30)

1. 1. Baillie TA and Rettenmeier AW, Valproate biotransformation, In: Antiepileptic Drugs (Eds. Levy RH, Mattson R, Meldrum B, Penry JK, Dreifuss FE), pp. 601-619. Raven Press New York, 1989.
2. 2. Dreifuss FE, Hepatic toxicity of valproate. In: Idiosyncratic Reactions to Valproate (Eds. Levy RH and Penry JK), pp. 9-12. Raven Press, New York, 1991.
3. 3. Engel AG and Rebouche CJ, Carnitine metabolism in inborn errors. J Inner Metab Dis (Suppl. 1) 7: 38-43, 1984.
4. 4. Roe CR, Millington DS, Maltby DA, Bohan TP and Hoppel CL, L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. J Clin Invest 73: 1785-1788, 1984.
5. 5. Chalmers RA, Roe CR, Stacy TE and Hoppel CL, Urinary excretion of L-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: Evidence for secondary insufficiency of 1-carnitine. Pediatr Res 18: 1325-1328, 1984.
6. 6. Melegh B, Kerner J and Bieber LL, Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochem Pharm 36: 3405-3409, 1987.
7. 7. Schmidt-Sommerfeld E, Penn D, Rinaldo P, Kossak BD, Li BUK, Huang ZH and Gage DA, Urinary medium-chain Acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 31: 545-551, 1992.
8. 8. Kossak BD, Schmidt-Sommerfeld E, Schoelle DA, Rinaldo P, Penn D and Tonsgard JH, Neurology 43: 2362, 1993.
9. 9. Riva R, Albani F, Gobbi G, Santucci M and Baruzzi A, Carnitine disposition before and during valproate therapy in patients with epilepsy. Epilepsia 34: 184-187, 1993.
10. 10. Nishida N, Sugimoto T, Araki A, Woo M, Sakane Y and Kobayashi Y, Carnitine metabolism in valproate-treated rats: The effect of L-carnitine supplementation. Pediatr Res 22: 500, 1987.
11. 11. Rozas I, Camina MF, Paz JM, Alonso C, Castro-Gago M and Rodrigez-Segade S, Effect of acute valproate administration on carnitine metabolism in mouse serum and tissues. Biochem Pharm 39: 181-185, 1990.
12. 12. Murakami K, Sugimoto T, Nishida N, Woo M, Araki A and Kobayashi YJ, Alterations of urinary acetylcarnitine in valproate-treated rats: The effect of L-carnitine supplementation. Child Neurol 7: 404-407, 1992.
13. 13. Bohan TP, Millington DS, Roe CR, Yergey AL and Liberto DJ, A novel metabolite of valproic acid, Ann Neurol 16: 394-398, 1984.
14. 14. Melegh B, Kerner J, Acsadi G, Lakatos J and Sandor A, L-Carnitine replacement therapy in chronic valproate treatment, Neuropediatrics 21: 40-43, 1990.
15. 15. Thein I, DiMauro S, Xie Z-W and De Vivo DC, Valproic acid impairs carnitine uptake in cultured human fibroblasts. An in vitro model for the pathogenesis of valproic acid-associated carnitine deficiency. Pediatr Res 34: 281-287, 1993.
16. 16. Cederblad G and Lindstadt S, A method for the determination of carnitine in the picomolar range. Clin Chim Acta 37: 235-243, 1972.
17. 17. Brass EP and Hoppel CL, Carnitine metabolism in the fasting rat. J Biol Chem 253: 2688-2693, 1978.
18. 18. Michal G and Bergmayer HU, Coenzyme A. In: Methods of Enzymatic Analysis vol. 4 (Ed. Bergmayer HU), pp. 1967-1987, Academic Press, New York, 1974.
19. 19. Michal G and Bergmayer HU, 2-Oxoglutarate. In: Methods of Enzymatic Analysis, vol. 3 (Ed. Bergmayer HU), pp. 1577-1580, Academic Press, New York, 1974.
20. 20. Michal G and Bergmayer HU, L-glutamate. A. In: Methods of Enzymatic Analysis, vol. 4 (Ed. Bergmayer HU), pp. 1705-1715, Academic Press, New York, 1974.
21. 21. Sandor A, Minkler PE, Ingalls ST and Hoppel CL, An enzymatic method for the determination of butyrobetaine via conversion to carnitine after isolation by high performance liquid chromatography. Clin Chim Acta 176: 17-28, 1988.
22. - form in sample processing for determination of carnitine. J Chrom 479: 250-257, 1989.
23. 23. Stadtman ET, Preparation and assay of acetyl-coenzyme A and other thiol esters; use of hydroxylamine. In: Methods Enzymology, vol. 3 (Eds. Colowick SP and Kaplan NO), pp. 931-941-Academic Press, New York, 1957.
24. 24. Ingalls ST, Hoppel CL and Turkaly JS, Synthesis of radioactively methyl-labe lied (1)-carnitine. J Label Comp Radiopharm 8: 535-541, 1981.
25. 25. Sandor A and Hoppel CL, Butyrobetaine availability in liver is a regulatory factor for carnitine biosynthesis in rat. Eur J Biochem 185: 671-675, 1989.
26. 26. Li J, Norwood DL, Mao LF and Schulz H, Mitochondrial metabolism of valproic acid. Biochemistry 30: 388-394, 1991.
27. 27. Gregus Z, Fekete T, Varga F and Klassen CD, Effect of valproic acid on glycine conjugation of benzoic acid. J Pharm Exp Ther 267: 1068-1075, 1993.
28. 28. Vanhove JLK, Kishnani P, Muenzer J, Wenstrup RJ, Summar ML, Brummond MR, Lachiewicz AM, Millington DS and Kahler SG, Benzoate therapy and carnitine deficiency in nonketotic hyperglycemia. Am J Med Gen 59: 444-453, 1995.
29. 29. Lindstedt G and Lindstedt S, Cofactor requirements of γ-butyrobetaine hydroxylase from rat liver. J Biol Chem 245: 4187-4192, 1970.
30. 30. Löscher W, Effects of the antiepileptic drug valproate on the metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem Res 18: 485-502, 1993.